Alzheimer's disease is associated with an early impairment of cognitive brain networks. The current study determines relationships between APOE4 carrier status, cortical iron, and cortical network-functionality.
for AD. These include mild cognitive impairment, 5, 6 increased burden of brain amyloid-(A ), [7] [8] [9] [10] [11] CNS proteinopathy, 12, 13 metabolic disorder, 14, 15 and vascular disease. 16, 17 Cognitive dysfunction in AD is preceded by progressive changes of intrinsic brain network activity. [18] [19] [20] [21] Here, cognitive networks such as the default mode network (DMN) are primarily affected. 19, [22] [23] [24] The DMN is constituted by a distinct connectivity pattern of synchronous cortical neuronal activity in spatially distant brain regions that include the medial prefrontal cortex (MPFC), lateral parietal cortices, posterior cingulate, and hippocampus, which are activated at rest. [25] [26] [27] There is a consistent link between APOE4 carrier status and increased A burden. 8, 9, 28 Interestingly, the effect of APOE4 on cognitive brain networks is present prior to accumulation of A , which may reflect risk for AD prior to manifestation of characteristic AD pathology. 29 Another pathological feature of AD is an increased burden of cerebral iron deposition. 30, 31 Although iron continuously accumulates in the human brain during aging, [32] [33] [34] [35] recently published postmortem data suggest an association between the amount of brain iron deposition and the progression and severity of cognitive decline in AD. [36] [37] [38] Moreover, associations between APOE4 carrier status, clinical phenotypes of increased risk for AD, and increased iron burden in the CNS have been demonstrated. 36, 39, 40 Paramagnetic susceptibility, as measured by quantitative susceptibility mapping (QSM) magnetic resonance imaging (MRI), has been demonstrated to closely relate to nonheme iron content of deep brain gray matter. [41] [42] [43] [44] Although myelin content is a major determinant of MR phase differences between cortical gray and white matter, 45 recently published histological data suggest that iron in cortical gray matter regions is a major contributor to susceptibility measured by QSM. 46 This approach is considered to provide an indirect estimate of non-heme iron in the brain, and associated risk for oxidative damage. 38, 47 By applying suitable post-processing techniques that balance susceptibility measures with reference regions and correct for heme iron and other non-tissue iron sources, strong linear correlations resulted between postmortem gray matter tissue iron concentration and QSM measurements. 43, 48 Consistently, several QSM-MRI studies demonstrated an association between increased tissue magnetic susceptibility, AD, and ADrisk phenotypes. 33, 40, 49, 50 Considering possible damaging impacts of brain iron burden on brain tissue by increased oxidative stress and redox activity, [51] [52] [53] [54] [55] [56] as well as programmed cell death conferred by ferroptosis, 57, 58 APOE might be a moderator for iron-related oxidative brain damage in individuals at risk for AD. 36, 59 In this context, cortical iron burden might indicate early cortical neurodegenerative alterations, as suggested by earlier published data of ours on brain iron in mild cognitive impairment. 40 Considering these prior studies, and allowing for the published evidence on earliest APOE4-moderated DMN alterations in cognitively unimpaired adults, 29, 60 we hypothesized that APOE4 may moderate the effects of increased cortical iron on cortical functionality, as reflected by DMN connectivity. Moreover, we hypothesized that APOE4-related changes should (a) be reflected by altered DMN activity and (b) precede the manifestation of significant AD pathology and cognitive dysfunction. To test this hypothesis, a study sample HIGHLIGHTS • Three-dimensional (3D) gradient recalled echo magnetic resonance imaging for quantitative susceptibility mapping (QSM) and 18F-flutemetamol positron emission tomography for amyloid-(A ) in healthy old-aged adults.
• Spatial definition and assessment of the default mode network (DMN) by group independent component analysis.
• Synergistic effects of iron (as measured by QSM) and APOE 4 allele (APOE4) on DMN connectivity.
• Interactive effects of APOE4 and QSM-iron may precede A pathology.
• APOE4 may accelerate brain iron accumulation associated DMN disintegrity.
RESEARCH IN CONTEXT
1. The apolipoprotein E 4 allele (APOE4) is the strongest known genetic risk factor for sporadic Alzheimer's disease (AD). APOE4-associated impairment of brainnetwork connectivity manifests prior to dementia. Considering recent reports on relationships between cerebral iron load, genetic risk, and progression of AD, our study aims at investigating the effects of APOE4 on cortical iron and cortical network connectivity in non-demented oldaged adults. Brain iron may be non-invasively inferred on by its paramagnetic properties using quantitative susceptibility mapping (QSM) magnetic resonance imaging. QSM is considered to provide an indirect estimate of non-heme iron.
2. Our findings suggest that APOE4 may moderate iron effects on brain functionality, as reflected by altered synchronized network activity, which is consistent with earlier reports on APOE4-related default mode network alterations. Additional studies are needed to clarify mechanisms implicated in the interaction between APOE4, cortical iron burden, and progression of cortical dysfunction in AD. of cognitively healthy, old-aged study participants was recruited.
All participants received genotyping for detection of APOE4 carrier status, 2 and 18F-flutemetamol positron emission tomography (PET) for assessing brain A burden. 61, 62 Blood oxygen level-dependent (BOLD) functional MRI (fMRI) at rest was performed for assessing intrinsic network connectivity, and the CONN toolbox 63 was used to identify the DMN by independent component analysis (ICA) 64 and statistical testing for interactive effects of APOE4 and cortical iron load, inferred from gray matter susceptibility.
MATERIALS AND METHODS

Study sample
The study sample included 69 cognitively healthy old-aged adults ( Exclusion criteria were presence of any condition possibly affecting cognition, any current medication or substance abuse with prompt effects on cognition, serious medical or psychiatric illness, and evidence of infarction or inflammation on cranial MRI. Furthermore, subjects with contraindications to MRI or PET, clinically relevant changes in red blood count, or significant exposure to radiation were excluded.
After inclusion, all participants received standardized cognitive testing and a clinical workup, including medical history, blood sampling, and genotyping of APOE as described earlier. 65 The study population was dichotomized based on presence of the APOE4 genotype ("APOE4 carriers" vs "non-carriers"), for stratification by genetic risk for sporadic, late-onset AD. 4 
Cognitive assessment of participants
Acquisition of MRI data and QSM
Acquisition of flutemetamol-PET data
18F-flutemetamol-PET was used for determination of participants A plaque burden, 61,62 as described earlier by our group. 65 
Identification of resting-state networks
To obtain functional connectivity networks of all 69 participants, we performed group spatial ICA 77 
Statistical analysis
The statistical analysis of fMRI data, as well as investigation of APOE4
and paramagnetic tissue iron effects on DMN connectivity, was performed using algorithms implemented in the CONN-toolbox (V17d). 63 As such, DMN activity was operationalized by level of BOLD synchronicity ( weights of connectivity) within the spatial confinement of the correspondent independent component. 77 Descriptives of the sample data are presented using mean ±SD.
Tests for differences in demographic, clinical, neuropsychological, or imaging-based (SUVR, QSM) parameters between subjects in the ApoE4-and no-ApoE4 group were performed with independent samples t tests. A median split of the study sample was used for separation of participants based on average cortical magnetic susceptibility:
QSM levels above or equal to the group median were categorized as "high cortical magnetic susceptibility" and QSM levels below the group median as "low cortical magnetic susceptibility." The resulting dichotomous variable was used as a categorical operator of cortical iron burden. (Figure 4 ). Finally, to compare regression effects attributable to APOE4 and cortical iron, respectively, a one-way ANCOVA interaction was performed by using second-level analysis algorithms included in CONN. 63 Additive synergism of APOE4 and iron effects was indicated by a positive relationship between cortical iron and DMN connectivity that was associated with APOE4 carrier status (T(65) = 3.22, P(FDR) < 0.001, Figure 5A ). Here, significant iron effects within the subgroup of APOE4 carriers were observed (F(2,16) = 10.97, P(FDR) = 0.0026, Figure 5B ). The strongest local effects consistently resulted for voxels localized in the posterior cingulate cortex, the precuneus, and lateral parietal cortex (Figures 5A, B) . 
RESULTS
Characteristics of the study population
Identification and spatial definition of the DMN
Synergistic interaction of APOE4 and cortical iron on default mode network activity
DISCUSSION
We identified a synergistic interaction of cortical gray matter susceptibility (QSM) and BOLD synchronicity at rest, suggesting a moderator effect of APOE4 on the relationship between cortical non-heme iron and DMN activity. This effect was observable in a population of old-aged, cognitively healthy adults. Because for the majority of the investigated participants no significant increase of A burden could be observed, our findings might reflect preclinical brain alterations associated with APOE4-related increased risk for AD.
The current study used established neuropsychological testing for assessment of cognitive domains typically affected in AD. 82 Moreover, all study participants were genotyped for presence of the APOE4 allele, allowing for additional stratification of the study population by individual risk for AD. 1, 4 Each participant also was investigated by 18F-flutemetamol PET to assess brain A burden. Flutemetamol has been used previously for assessing patients with AD, 61, 62 as well as cognitively unimpaired old-aged adults. 83, 84 Although there was no significant difference between APOE4 carriers and non-carriers regarding A pathology, longitudinal follow-up of our sample might reveal possible faster accumulation of brain A in the APOE4 group, as suggested by earlier reports. 10, 85 Considering the synchronicity of BOLD contrast variation in spatially distinct brain regions a proxy of neuronal functionality, 25, 26, 86 ICA was performed for detection and statistical group-inferences. 63, 77 Blind source decomposition is capable of identifying many different brain networks from fMRI data recorded at rest. 26, 64 In the current study we focused on the DMN, considering earlier studies that provide evidence that DMN connectivity is an indicator of cognitive functionality, 25, 27, 87 which is affected at early, preclinical stages of AD. 18, 19, 21, 22, 84 Although the chosen focus on the DMN may be a limitation regarding general inferences on global intrinsic network activity, the unambiguous spatial characteristics of the DMN component may have facilitated differentiation from components representing noise. Iron burden was assessed using QSM, 44, 47, 88 which is a potential pathology in AD and AD-risk populations. 40, 49, 50, 89 A close association between paramagnetic susceptibility in gray matter brain regions (with low myelin content) and high tissue iron content is supported by post mortem analysis of deep brain gray matter. 43, 90 Recently published histological data on cortical and deep gray matter regions furthermore support a positive relationship between QSM and iron, and an inverse relationship between QSM and myelin. 46 Although paramagnetic susceptibility in human gray matter is regarded as a valid measure of non-heme iron, 38, 91 particularly cortical susceptibility measures should be interpreted carefully. When inferring on local non-heme iron, myelin may have a confounding impact due to its phase shifting capacity. 45 Moreover, there may be a relationship between susceptibility measured by locally increased BOLD contrast and QSM.
Although the current study investigated BOLD synchronicity over time rather than local increases of BOLD contrast, the fact that BOLD and QSM may not be completely independent might nevertheless represent another limitation of our experimental approach. In addition, QSM at higher spatial resolution might reduce the risk of confounding heme iron by vascular objects that may have been missed due to SNR limitations of the 3 Tesla GRE sequence applied here. Further studies implying an additional, independent measure of blood flow might provide insight on the interdependence of both measures.
Although our data are consistent with earlier reports on an association between APOE4 and altered DMN properties in preclinical stages of AD, 29 our findings of an association between APOE4 and increased DMN connectivity may be consistent with earlier considerations that increased DMN connectivity might represent characteristic phenomena in populations at risk for AD. 84 Moreover, the finding of a genotype effect may corroborate biological relevance of our observation. Our main finding was that APOE4 effects synergistically interacted with effects associated with increased brain iron (as estimated by QSM). To our knowledge no interactive effects between magnetic susceptibility, as a reflection of iron, and APOE4 on DMN activity have been reported so far. However, our findings support earlier considerations that detrimental effects associated with increased brain iron may be promoted by the APOE4 genotype. 36, 59, 89 Although the APOE4 genotype alone is not associated with increased iron, 37 increased prevalence of APOE4 in cognitively impaired individuals with higher levels of brain iron might reflect accelerated cognitive deterioration. 39, 40 Moreover, recently published data suggest that alterations of cortical networks such as the DMN may also indicate progression of tau pathology. 92, 93 Here, additional longitudinal studies are needed to carefully investigate potential interactions between pathological tau and iron in neurodegenerative disease and healthy aging. 94 Our current findings of a possibly synergistic impact of paramagnetic susceptibility and APOE4 on BOLD synchronicity within the DMN might support recently suggested therapeutic interventions aimed at brain iron load 54, 95 but also restoring physiological network architecture within the neocortex. 96 Recent studies suggest potentially deleterious effects of unbound iron by oxidative stress 52, 97 or programmed cell death such as ferroptosis, 58 an association of brain iron burden with life style, 98 and a possible role of iron for maintained cognitive function at old age. 65 Thus, longitudinal cohort studies are needed to better understand the interplay between altered MR measures of cortical susceptibility, its relationship to dysbalanced brain iron homeostasis, and APOE4-related risk for AD.
